FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and concerns an oral pharmaceutical composition for treating inflammatory gastrointestinal diseases containing sodium alginate, a functional additive and water. As a functional additive, the composition contains dipeptide glutamyl-tryptophane.
EFFECT: invention provides higher efficacy of the composition in treating inflammatory gastrointestinal diseases.
1 cl, 6 ex, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TETRAPEPTIDE STIMULATING FUNCTIONAL ACTIVITY OF HEPATOCYTES, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USE | 2000 |
|
RU2166957C1 |
| COMBINED AGENT CONTAINING UDCA, HYMECROMONE AND SILYMARIN (VERSIONS) | 2017 |
|
RU2738444C2 |
| THERAPEUTIC USE OF KERATINOCYTE GROWTH FACTOR | 1994 |
|
RU2146148C1 |
| PHARMACEUTICAL COMPOSITION FROM GALLERIA MELLONELLA LARVAE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2741801C2 |
| APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
| PEPTIDE STIMULATING REGENERATION OF LIVER TISSUE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2297239C1 |
| METHOD OF DOG'S HEPATOSIS THERAPY | 2012 |
|
RU2490018C1 |
| HEPATOPROTECTIVE AND ANTIHEPATOTOXIC PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATIC DISEASES THAT INVOLVES INTRODUCTION OF SAID COMPOSITION | 2008 |
|
RU2381800C1 |
| USING ACIZOL AS HEPATOPROTECTING AGENT | 2004 |
|
RU2260427C1 |
| RECTAL POLYCOMPLEX GEL FOR TREATMENT OF ULCERATIVE COLITIS, CROHN'S DISEASE, FISTULAS AND COMPLICATIONS CAUSED BY THESE DISEASES | 2014 |
|
RU2605615C2 |
